Completed

Genetics of Ankylosing Spondylitis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Spondylitis

+ Ankylosing Spondylitis
How is the trial designed

Other

Observational
Study Start: September 1999

Summary

Principal SponsorNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Last updated: February 21, 2008
Sourced from a government-validated database.Claim as a partner
Study start date: September 1, 1999Actual date on which the first participant was enrolled.

Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects the joints between the vertebrae of the spine and the joints between the spine and the pelvis. The purpose of this study is to collect information and blood samples from patients with AS and their relatives for use in genetic studies. AS is a chronic inflammatory disease that eventually causes the affected vertebrae to fuse or grow together. The cause of AS is unknown, but genetic factors seem to play a role. Risk factors include a family history of ankylosing spondylitis and male gender. This study will collect patient information and blood samples from affected patients (and when available, both parents of the affected patients) of 400 families with children fulfillling the modified New York criteria for AS. Diagnosis of AS will be verified by patient questionnaire, medical record review, and pelvic radiographs. Information from these patients will be used to search the human genome for disease-associated loci and/or genes. This study will also utilize contributions of investigators who have conducted recent clinical or genetic research in AS at 10 academic medical centers throughout North America (the North American Spondylitis Consortium, or NASC).

Official TitleFamily Studies of the Genetics of Ankylosing Spondylitis 
Principal SponsorNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Last updated: February 21, 2008
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
1600 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Healthy volunteers allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Spondylitis
Ankylosing Spondylitis
Criteria

Inclusion Criteria: * Meet modified New York criteria for ankylosing spondylitis (AS) * AS as confirmed by X-rays of sacroiliac joints (between the pelvis and spine) * At least two siblings in family with AS * Parents of the participants with AS have the option of also being enrolled



Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 2 locations
Suspended
Cedars-Sinai Medical CenterLos Angeles, United StatesSee the location
Suspended
University of Texas - Health Science Center at HoustonHouston, United States

Completed2 Study Centers